This topic has perhaps already been discussed, but I did not see it upon a quick glance. Here were eight points given as to how Ivermectin can be used as an effective treatment for COVID-19:
- Inhibits binding at ACE2 and TMPRSS2, keeping the virus from entering our cells.
- Blocks alpha/beta importin (the virus cell taxi), keeping it from getting to the nucleus.
- Blocks the viral replicase zipper (RdRp).
- 3-Chimotrypsin protease inhibition (keeps the virus from assembling).
- Ivermectin strengthens our natural antiviral cell activity by increasing our natural interferon production (this counters SARSCOV2 activity, which inhibits cellular interferon).
- Decreases IL-6 and other inflammatory cytokines through NF Kappa Beta downregulation, taking the patient from a cytokine storm to calm.
- Binds NSP14, necessary for viral replication, and blocks it (equals less virus).
- Most important mechanism is inhibiting binding to CD147 receptor on red cells, platelets, lung, and blood cell lining. Ivermectin keeps the virus from binding here and decreases deadly clotting.
The mechanism that I am interested in is that Ivermectin acts as a protease inhibitor that is effective at reducing the ability of the SARS-CoV-2 virus to replicate. Based on this mechanism, as well as the eight points above, is there specific information refuting that Ivermectin reduces the ability of the SARS-CoV-2 virus to reproduce itself as described?